[1]
Abravan, A. et al. 2022. Effect of systemic inflammation biomarkers on overall survival after lung cancer radiotherapy: a single-center large-cohort study. Acta Oncologica. 61, 2 (Feb. 2022), 163–171. DOI:https://doi.org/10.1080/0284186X.2021.2022201.